Review article · 2022 · Open access
Nanoparticle-based immunotherapy of pancreatic cancer
Frontiers in Molecular Biosciences, 9, 948898 · Published 29 August 2022 · DOI 10.3389/fmolb.2022.948898
In brief
“Nanoparticle-based immunotherapy of pancreatic cancer” is a 2022 review article by Gaetan Aime Noubissi Nzeteu and 5 co-authors, published in Frontiers in Molecular Biosciences. OpenAlex counts 31 citations as of 21 November 2026. It is open access under a CC BY licence: the full text is free to read at Frontiers in Molecular Biosciences.
- Citations
- 31
- Most cited in
- 2023 (11)
- Field-weighted impact
- 0.36
- References
- 116
- Authors
- 6
Abstract
Pancreatic cancer (PC) has a complex and unique tumor microenvironment (TME). Due to the physical barrier formed by the desmoplastic stroma, the delivery of drugs to the tumor tissue is limited. The TME also contributes to resistance to various immunotherapies such as cancer vaccines, chimeric antigen receptor T cell therapy and immune checkpoint inhibitors. Overcoming and/or modulating the TME is therefore one of the greatest challenges in developing new therapeutic strategies for PC. Nanoparticles have been successfully used as drug carriers and delivery systems in cancer therapy. Recent experimental and engineering developments in nanotechnology have resulted in increased drug delivery and improved immunotherapy for PC. In this review we discuss and analyze the current nanoparticle-based immunotherapy approaches that are at the verge of clinical application. Particularly, we focus on nanoparticle-based delivery systems that improve the effectiveness of PC immunotherapy. We also highlight current clinical research that will help to develop new therapeutic strategies for PC and especially targeted immunotherapies based on immune checkpoint inhibitors.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Nzeteu, G. A. N., Gibbs, B. F., Kotnik, N., Troja, A., Bockhorn, M., & Meyer, N. H. (2022). Nanoparticle-based immunotherapy of pancreatic cancer. Frontiers in Molecular Biosciences, 9, 948898. https://doi.org/10.3389/fmolb.2022.948898
MLA 9
Nzeteu, Gaetan Aime Noubissi, et al. “Nanoparticle-based immunotherapy of pancreatic cancer.” Frontiers in Molecular Biosciences, vol. 9, 2022, p. 948898. https://doi.org/10.3389/fmolb.2022.948898.
Chicago
Nzeteu, Gaetan Aime Noubissi, Bernhard F. Gibbs, Nika Kotnik, Achim Troja, Maximilian Bockhorn, and N. Helge Meyer. 2022. “Nanoparticle-based immunotherapy of pancreatic cancer.” Frontiers in Molecular Biosciences 9: 948898. https://doi.org/10.3389/fmolb.2022.948898.
Harvard
Nzeteu, G. A. N. et al. (2022) ‘Nanoparticle-based immunotherapy of pancreatic cancer’, Frontiers in Molecular Biosciences, 9, p. 948898. doi:10.3389/fmolb.2022.948898.
IEEE
G. A. N. Nzeteu, B. F. Gibbs, N. Kotnik, A. Troja, M. Bockhorn, and N. H. Meyer, “Nanoparticle-based immunotherapy of pancreatic cancer,” Frontiers in Molecular Biosciences, vol. 9, p. 948898, 2022, doi: 10.3389/fmolb.2022.948898.
BibTeX
@article{nzeteu2022nanoparticle,
title = {{Nanoparticle-based immunotherapy of pancreatic cancer}},
author = {Nzeteu, Gaetan Aime Noubissi and Gibbs, Bernhard F. and Kotnik, Nika and Troja, Achim and Bockhorn, Maximilian and Meyer, N. Helge},
journal = {Frontiers in Molecular Biosciences},
year = {2022},
volume = {9},
pages = {948898},
doi = {10.3389/fmolb.2022.948898},
url = {https://doi.org/10.3389/fmolb.2022.948898}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2022 | 1 | |
| 2023 | 11 | |
| 2024 | 6 | |
| 2025 | 5 | |
| 2026 | 8 |
Its field-weighted citation impact is 0.36: it has been cited 0.36 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- pancreatic cancer
- tumor microenvironment
- desmoplastic stroma
- drug delivery
- immune checkpoint inhibitors
- targeted immunotherapy
- cancer vaccines
- CAR T-cell therapy
Work with this paper
Most-cited papers in Materials Science
- Electric Field Effect in Atomically Thin Carbon FilmsKostya S. Novoselov, Andre K. Geim, Sergey V. Morozov and 5 more · Science · 2004 · 67,474 citations
- Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenidesROBERT D. SHANNON · Acta Crystallographica Section A · 1976 · 66,944 citations
- Ab initio molecular dynamics for liquid metalsGeorg Kresse, J. Häfner · Physical review. B, Condensed matter · 1993 · 46,320 citations
- Helical microtubules of graphitic carbonSumio Iijima · Nature · 1991 · 43,639 citations
- The rise of grapheneAndre K. Geim, Kostya S. Novoselov · Nature Materials · 2007 · 40,328 citations
Questions about this paper
How do I cite this paper in APA style?
Nzeteu, G. A. N., Gibbs, B. F., Kotnik, N., Troja, A., Bockhorn, M., & Meyer, N. H. (2022). Nanoparticle-based immunotherapy of pancreatic cancer. Frontiers in Molecular Biosciences, 9, 948898. https://doi.org/10.3389/fmolb.2022.948898
How many times has this paper been cited?
31 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Frontiers in Molecular Biosciences: sign in and open the PDF from this page.
Who wrote this paper?
Gaetan Aime Noubissi Nzeteu, Bernhard F. Gibbs, Nika Kotnik, Achim Troja, Maximilian Bockhorn, N. Helge Meyer.
What is the DOI of this paper?
10.3389/fmolb.2022.948898, permanently at https://doi.org/10.3389/fmolb.2022.948898. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.